Nimenrix 0.5 ml/prefilled syringe (IM Injection)
0.5 ml prefilled syringe: ৳ 4,500.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Meningococcal conjugate vaccine |
| Company | Pfizer |
Indications
- Active immunisation against invasive meningococcal diseases caused by Neisseria meningitidis group A, C, W-135, and Y
Composition
- Neisseria meningitidis group A polysaccharide 15 micrograms
- Neisseria meningitidis group C polysaccharide 15 micrograms
- Neisseria meningitidis group W-135 polysaccharide 15 micrograms
- Neisseria meningitidis group Y polysaccharide 15 micrograms
Pharmacology
- Anti-capsular meningococcal antibodies protect against meningococcal diseases
- Induces production of bactericidal antibodies against capsular polysaccharides of Neisseria meningitidis group A,C,W-135 and Y
Dosage
- Two doses for infants from 6 weeks to less than 6 months of age
- Single dose for infants from 6 months of age, children, adolescents and adults
- Booster doses recommended
- Administration by intramuscular injection
Administration
- Intramuscular injection recommended
- Recommended injection site in infants and individuals aged 1 year and above
Interaction
- Can be given concomitantly with other vaccines
- Co-administration recommendations for different age groups
- Impact of co-administration on immune responses
- Administration at different injection sites when given with other injectable vaccines
- Possible effect in patients receiving immunosuppressive treatment
Contraindications
- Hypersensitivity to the active substances or excipients
Side Effects
- Appetite lost
- Irritability
- Insomnia
- Crying
- Drowsiness
- Headache
- Hypoaesthesia
- Dizziness
- Diarrhoea
- Vomiting
- Nausea
- Pruritus
- Rash
- Myalgia
- Pain in extremity
- Fever
- Swelling at injection site
- Pain at injection site
- Redness at injection site
- Fatigue
- Injection site haematoma
- Malaise
- Injection site induration
- Injection site pruritus
- Injection site warmth
- Injection site anaesthesia
Pregnancy & Lactation
- Limited experience in pregnant women
- Animal studies do not indicate harmful effects in pregnancy or lactation
- Use during pregnancy and lactation should consider potential risks and benefits
Overdose Effects
- No case of overdose reported
Therapeutic Class
- Vaccines, Anti-sera & Immunoglobulin
Storage Conditions
- Refrigeration between 2°C-8°C
- Protection from light